An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer

W. M. Alberts (Tampa, United States of America)

Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer

Slide presentation

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. M. Alberts (Tampa, United States of America). An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer. Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Missed lung cancer on chest radiography – does it affect the outcome?
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007



The chest physician as the lung cancer patient’s guide: defining the role of the modern day chest physician throughout the lung cancer continuum
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017


Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


How should PET influence the management of lung cancer?
Source: Annual Congress 2013 –ME11 How should PET influence the management of lung cancer?
Year: 2013


Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012



Delays in lung cancer management
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005

Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


COVID-19 and the management of thoracic cancer patients: challenges and recommendations
Source: ERS webinar 2020: COVID-19 and the management of thoracic cancer patients: challenges and recommendations
Year: 2020


The evidence on CT: lung cancer screening
Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice
Year: 2018

Dealys in the diagnosis and treatment of lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 458s
Year: 2004

Lung cancer: clinical presentation and specialist referral time
Source: Eur Respir J 2004; 24: 898-904
Year: 2004



Our diagnostic time for lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 322s
Year: 2005

The role of bronchoscopy in the diagnosis of lung cancer: an audit to assess standards
Source: Eur Respir J 2001; 18: Suppl. 33, 62s
Year: 2001

Factors determining early adherence to a lung cancer screening protocol
Source: Eur Respir J 2007; 30: 532-537
Year: 2007



The role of bronchoscopy in the diagnosis of lung cancer and other diseases
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009

The need for early MDT assessment of lung cancer patients presenting with pain
Source: Eur Respir J 2003; 22: Suppl. 45, 432s
Year: 2003